The page, intended for clinicians, nurses and other investigators working on this multi-centre trial in the UK and Ireland, supports what is now the largest ever trial investigating pyoderma gangrenosu. The study is currently running in around 50 hospitals throughout the UK and Ireland to investigate the best way of treating the rare skin disease which causes painful ulcers on the skin and can take many months to heal.
The trial is being coordinated by the Nottingham Clinical Trials Unit and the UK Dermatology Clinical Trials Network at the University of Nottingham and Nottingham University Hospitals NHS Trust. STOP GAP stands for ‘Study of Treatments for Pyoderma Gangrenosum patients’.
The trial’s website has further information about the study for both patients and professionals.